NASDAQ
Artiva Biotherapeutics, Inc. (ARTV) has a free cash flow growth of -39.91% as of Friday, May 29, 2026. This represents a 943.48% decrease compared to its 12-month average of -3.82%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.